Literature DB >> 10424538

Management of aortobronchial fistula with an aortic stent-graft.

R Karmy-Jones1, C A Lee, S C Nicholls, E Hoffer.   

Abstract

Aortobronchial fistula presenting as massive hemoptysis is a rapidly fatal process that is extremely difficult to manage. We report a case in which endovascular occlusion of a fistula between a thoracic aortic pseudoaneurysm and lung was successfully managed by placement of an aortic endovascular stent-graft. Stent-grafting is a promising technique in managing complications of thoracic aneurysms and grafts.

Entities:  

Mesh:

Year:  1999        PMID: 10424538     DOI: 10.1378/chest.116.1.255

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Unusual complications of endovascular repair of the thoracic aorta: MDCT findings.

Authors:  T Valente; G Rossi; F Lassandro; G Rea; M Marino; G Dialetto; R Muto; M Scaglione
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

2.  Surgical treatment of aortobronchial and aortoesophageal fistulae due to thoracic aortic aneurysm.

Authors:  Ercan Eren; Cuneyt Keles; Mehmet Erdem Toker; Suat Ersahin; Vedat Erentug; Mustafa Guler; Gokhan Ipek; Esat Akinci; Mehmet Balkanay; Cevat Yakut
Journal:  Tex Heart Inst J       Date:  2005

3.  Endovascular stenting for primary aortobronchial fistula in association with massive hemoptysis.

Authors:  John Kokotsakis; Panagiotis Misthos; Thanos Athanasiou; Constantina Romana; Elian Skouteli; Achilles Lioulias; Ioannis Kaskarelis
Journal:  Tex Heart Inst J       Date:  2007

4.  Endovascular Repair of Aortobronchial Fistula due to Saccular Aneurysm of Thoracic Aorta.

Authors:  Konstantinos Tigkiropoulos; Kyriakos Stavridis; Ioannis Lazaridis; Nikolaos Saratzis
Journal:  Case Rep Vasc Med       Date:  2017-11-27

5.  Fatal bronchovascular fistula after a single lung transplantation: a case report.

Authors:  Marcos Naoyuki Samano; Juliana Akemi Saka; Marlova Luzzi Caramori; Paulo Manuel Pêgo-Fernandes; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.